SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Focused Visit (Follow-up) — Mark Twain

PatientSamuel Langhorne Clemens
Date of birth1956-11-30
IdentifiersMRN HR-NI013-SYN; SSN (made up) 000-13-2964
Document date2026-09-11
AuthorWinifred Achterberg-Lowe, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Thirteen-week review: grief therapy, smoking, a gout flare while away, urate and lipids. [S]

History of Present Illness

Mr. Clemens returns eight weeks after his five-week review, after nearly three weeks away in August. Two days after he left, his right big toe became hot, swollen and too painful to walk on; a doctor where he was staying prescribed prednisone 40 mg for five days, and he kept taking allopurinol and colchicine as told. The flare settled within a week. Because he was away, the urate test planned three to four weeks after starting allopurinol was not done until today. He stopped smoking on his quit date at the start of August, smoked two cigars one evening while away, and none since; varenicline causes mild nausea only. His bronchitis from the sick visit has cleared. He has had eleven grief therapy sessions, two of them by telephone while away; he missed one. He sleeps about six hours, writes most mornings and has begun to see friends. No chest tightness. [S]

ElementDetail
GoutA flare while away, treated with prednisone; allopurinol continued
TobaccoQuit at the start of August; one lapse of two cigars; none for three weeks
Grief therapyEleven sessions, two by telephone; PG-13-R 32
ChestNo tightness since July
Results todayUrate 7.4 mg/dL; LDL 74 mg/dL; ALT 28 U/L; creatinine 1.10 mg/dL

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy better; weight up
CardiovascularNegativeNo chest tightness
MusculoskeletalNegativeToe recovered; no muscle aches
PsychiatricPositiveGrief easing; no thoughts of death

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four daysOne tablet daily on days 1 to 3, then twice daily on days 4 to 7Oral route2026-07-17 to 2026-07-24completedS
Varenicline 1 mg oral tablet, one tablet twice daily with food for twelve weeks, with a quit date in the second weekOne tablet twice daily with foodOral route2026-07-24activeS
Atorvastatin 40 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-07-17activeS
Aspirin 81 mg delayed-release oral tablet, one tablet dailyOne tablet dailyOral route2026-07-17activeS
Allopurinol 100 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-07-17 to 2026-09-11completedS
Allopurinol 100 mg oral tablet, two tablets daily (200 mg)Two tablets dailyOral route2026-09-11 to 2026-10-16completedS
Colchicine 0.6 mg oral tablet, one tablet daily for flare prevention while allopurinol is started, for three to six monthsOne tablet dailyOral route2026-07-17activeS
Prednisone 20 mg oral tablet, two tablets (40 mg) each morning for five days, for a gout flare, prescribed by a doctor where he was stayingTwo tablets each morning for five daysOral route2026-08-12 to 2026-08-16completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-11Body height173cmS
2026-09-11Body weight64.9kgS
2026-09-11Body mass index (BMI) [Ratio]21.7kg/m2S
2026-09-11Systolic blood pressure130mm[Hg]S
2026-09-11Diastolic blood pressure78mm[Hg]S
2026-09-11Heart rate72/minS
2026-09-11Respiratory rate14/minS
2026-09-11Body temperature36.6CelS
2026-09-11Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-11Cholesterol [Mass/volume] in Serum or Plasma156mg/dL<=199 mg/dLNormalS
2026-09-11Cholesterol in HDL [Mass/volume] in Serum or Plasma46mg/dL>=40 mg/dLNormalS
2026-09-11Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation74mg/dL<=99 mg/dLNormalS
2026-09-11Triglyceride [Mass/volume] in Serum or Plasma180mg/dL<=149 mg/dLHighS
2026-09-11Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L7-56 U/LNormalS
2026-09-11Urate [Mass/volume] in Serum or Plasma7.4mg/dL3.5-7.2 mg/dLHighS
2026-09-11Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-09-11Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-09-11Creatinine [Mass/volume] in Serum or Plasma1.1mg/dL0.74-1.35 mg/dLNormalS
2026-09-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M73mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-09-11Glucose [Mass/volume] in Serum or Plasma98mg/dL70-99 mg/dLNormalS
2026-09-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S

Physical Exam

Vital signs recorded on 2026-09-11; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 130/78, pulse 72; weight 64.9 kg
RespiratoryClear
MusculoskeletalRight first toe joint normal; no tophi
PsychiatricEngaged and humorous; speaks of his wife with less pain

Problems

ProblemClinical statusVerificationCodeProvenance
Persistent yearning for his wife, broken sleep, low mood and withdrawal from friends and work, a year after her death; cause under evaluationresolvedconfirmed Z63.4S — Synthetic presenting problem anchored to his wife's documented death a year before; resolved into the diagnosis of prolonged grief disorder at the consultation. Not a claim about his real grief.
Prolonged grief disorder (DSM-5-TR): more than 12 months after his wife's death, daily yearning and preoccupation with her, with intense emotional pain, a sense that part of himself has died, avoidance of reminders, loneliness, difficulty taking up his work and life again, and a feeling that life is meaningless; PG-13-R 41; major depression not presentactiveconfirmed F43.81S — Synthetic modern diagnosis made at the consultation, anchored to his documented bereavements. Not a claim about his real mental health; the roster's bipolar lead is not used.
Tobacco use disorder, cigars: about fifteen cigars a day, smoking since boyhood, some smoke inhaled; first cigar within thirty minutes of wakingactiveconfirmed F17.290S — Synthetic modern coding anchored to his documented smoking since boyhood.
Chest tightness on climbing steep hills, twice in the past month, easing within five minutes of rest; none at rest; cause under evaluationresolvedconfirmed R07.89S — Synthetic presenting symptom; resolved into a diagnosis at five weeks after CT coronary angiography. Not a claim about his real heart in 1905; his documented chest pain began in 1909.
Coronary artery disease, nonobstructive (CAD-RADS 2: 25 to 49 percent narrowing of the proximal left anterior descending artery; coronary calcium score 410), with exertional chest tightness that has not recurred on treatment; treated with a statin, aspirin and stopping smokingactiveconfirmed I25.10S — Synthetic modern diagnosis made at five weeks. Not a claim about his real coronary arteries.
Gout, recurrent flares of the big toe since his late fifties, two in the past year; serum urate 8.6 mg/dL; no tophiactiveconfirmed M10.9S — Synthetic modern diagnosis anchored to his documented gout.
Acute bronchitis, likely viral, for six days in a cigar smoker; no pneumonia on examination; resolved within three weeks without antibioticsresolvedconfirmed J20.9S — Synthetic acute illness; not a historical claim; his documented bronchitis was in later years.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyGrief severity (PG-13-R) and the DSM-5-TR prolonged grief disorder criteriaAt diagnosis and every four weeks during therapyCompleted todayPG-13-R 32
ReferralProlonged grief disorder therapy: sessions attendedWeekly for sixteen weeksCompleted todayEleven sessions, two by telephone while away; one missed
SurveyDepression (PHQ-9), to watch for major depressionAt baseline and every four weeks during treatmentCompleted todayPHQ-9 7, item 9 scored 0
SurveySuicide risk review, safety plan, means safety and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of death; safety plan kept
Self-managementSleep, without sedative-hypnoticsEvery visitCompleted todayAbout six hours
Self-managementSocial contact and his writingEvery visitCompleted todayWriting most mornings; seeing friends weekly
Self-managementTobacco use (cigars a day), readiness and counselingEvery visitCompleted todayNo cigars for three weeks after one lapse
Medication safetyVarenicline: adherence, nausea, sleep and mood changesEvery visitCompleted todayMild nausea only; no change in mood or sleep from varenicline
ExaminationChest symptoms on exertionEvery visitCompleted todayNone since July
ExaminationBlood pressureEvery visitCompleted today130/78 mmHg
LaboratoryLipid panel and ALT on a statin4 to 12 weeks after starting, then every 3 to 12 monthsCompleted todayEight weeks on atorvastatin: total cholesterol 156, HDL 46, LDL 74 (51 percent lower), triglycerides 180 mg/dL; ALT 28 U/L
Medication safetyAspirin and statin adherence, bleeding and muscle symptomsEvery visitCompleted todayTaking both daily; no bleeding or muscle aches
LaboratorySerum urate during allopurinol titrationEvery 2 to 5 weeks while titrating, then every 6 monthsDeferredThe check due three to four weeks after starting allopurinol was missed while he was away, which delayed the first dose increase by about four weeks; a flare occurred in that time, but flares are common early in treatment and he had no lasting harm. Today 7.4 mg/dL. Corrective action: urate four to five weeks after each change at a laboratory near wherever he is staying
Self-managementGout flares and colchicine prophylaxisEvery visitCompleted todayOne flare in August treated with prednisone while away; allopurinol and colchicine continued
LaboratoryKidney function on allopurinol and colchicineWith each urate checkCompleted todaySodium 139, potassium 4.5 mmol/L, creatinine 1.10 mg/dL, eGFR 73, glucose 98 mg/dL

Goal progress:

Guideline basis: Prolonged Grief Disorder (DSM-5-TR criteria, patient and family information) (2022); Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale (2021); Treatment of complicated grief: a randomized controlled trial (2005); Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial (2016); Loss of partner and suicide risks among oldest old: a population-based register study (2004); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2020 American College of Rheumatology Guideline for the Management of Gout (2020); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease, hyperlipidemia, and depression, bipolar, and mood disorders monographs (2026)

Follow-up: Annual wellness visit in two weeks. Eighteen-week review in five weeks with a urate test. Call the clinic or 988 at any time. Next scheduled visit 2026-09-25: subsequent annual wellness visit. [S]